New research published about our treatment
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
Stanley T. Lewis Frank Greenway Tori R. Tucker Michael Alexander Levonika K.
Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action
Candida J. Rebello Tyler S. Morales Katsya Chuon Shu Dong V. Tyrone
Improved HOMA-IR Insulin Sensitivity and Glycemic Control Utilizing Physiologic Insulin Resensitization
Brian Loveridge Michael Alexander Zach Villaverde Natalie Parkin Shelley Messerly Jonathan RT
Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization
Randal T. Pham Aarin Pham-Hoang Stanley T. Lewis Frank Greenway Amr Dessouki
Insulin Infusion Therapy on Diabetic Complications, Medications, Quality of Life, Hemoglobin A1C, and Metabolic Functioning: Retrospective Analyses￼￼
Kim Dunn, MD, Ph.D. David Hayes, Pharm.D. Sandra Petersen, DNP William J.
Emily Hartley and Alina Maleski Smith, MHA Department of Internal Medicine Mercer
Zach Villaverde, Island Doctors, St. Augustine, FL with Well Cell Global, Houston,
Tori Tucker, Jennifer Hadley, Michael Alexander, Jonathan RT Lakey and Brian Loveridge
Brian Loveridge Tori Tucker Melanie St. Laurent Scott Hepford Michael Alexander Jonathan
Frank Greenway 1, Brian Loveridge 2, Richard M. Grimes 3, Tori R.